JPS6043387A - Antitumor agent and its preparation - Google Patents

Antitumor agent and its preparation

Info

Publication number
JPS6043387A
JPS6043387A JP58151417A JP15141783A JPS6043387A JP S6043387 A JPS6043387 A JP S6043387A JP 58151417 A JP58151417 A JP 58151417A JP 15141783 A JP15141783 A JP 15141783A JP S6043387 A JPS6043387 A JP S6043387A
Authority
JP
Japan
Prior art keywords
water
reaction
sulfuric acid
substance
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58151417A
Other languages
Japanese (ja)
Other versions
JPS6141551B2 (en
Inventor
Takuma Sasaki
琢磨 佐々木
Masanori Shinozaki
篠崎 昌敬
Shoichi Kitano
正一 北野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP58151417A priority Critical patent/JPS6043387A/en
Publication of JPS6043387A publication Critical patent/JPS6043387A/en
Publication of JPS6141551B2 publication Critical patent/JPS6141551B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

PURPOSE:To obtain a novel antitumor agent, by fermenting grain by Rhizopus oryzae M-24 strain, collecting a water-soluble component in the fermented solution. CONSTITUTION:Grain such as polished rice, waste rice, etc. is fermented by Rhizopus oryzae M-24 strain (FERM-P 7195) by koji process. The koji is extracted with water to give a water-soluble substance, which is subjected to spray drying, to give an antitumor agent. This antitumor agent has the following physical properties. Elemental analysis value (about): C 40%, H 7%, and N 1%. Molecular weight: 5,000-100,000. Melting point: decomposing at >=220 deg.C. Solubility in solvent: easily soluble in water, insoluble in methnol, ethanol, chloroform, ether, acetone, ethyl acetate, and n-hexane. Color of substance: white. Saccharide content: 85-90wt% calculated as glucose measured by phenol-sulfuric acid method.

Description

【発明の詳細な説明】 本発明は新規な抗腫瘍性物質並ひに本発明者によって分
離固定されたリゾプス・オリーゼ−(Rh1zopus
 oryzae ) M −24株を使用する抗腫瘍性
物質の製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides novel antitumor substances as well as Rhizopus oryzae isolated and fixed by the present inventor.
oryzae) M-24 strain.

糸状菌類、すなわちリゾプス・オリーゼ−を種々の穀類
に作用させて発酵させ醸造物を製造することが行われて
いる。しかし、該菌を、硫酸アンモン、(llit酸マ
グネシウム、第一リン酸カリウム、炭酸カリウム、炭酸
カルシウム、ブドウ糖、寒天からなる従来の培地で培養
したものは、#素泊性が比較的弱く、そのため糖化力及
び有機酸類の生産量が低いという欠府があった。
BACKGROUND ART Brewed products are produced by fermenting various grains by using filamentous fungi, namely Rhizopus oryzae. However, when this bacterium is cultured in a conventional medium consisting of ammonium sulfate, (magnesium llitate, monobasic potassium phosphate, potassium carbonate, calcium carbonate, glucose, and agar), its propagation property is relatively weak; It was lacking in saccharification power and production of organic acids.

そこで、本発明者tl’ 、該餉の酵素活性を向上せし
めんと鋭童仙究を行い、粉末化した粘板岩の抽出物を基
本培養基として該菌を培養し、その胞子等を無菌の砂中
で純粋培養を繰り返1〜た結果、強い酵素活性を有する
固定された菌株が得られること、並びに驚くべきことに
、該菌株を用いて穀類を発酵さぜると、優れた抗腫瘍性
物質か産生されることを見出し、本発明を完成した。
Therefore, the present inventor tl' carried out extensive research to improve the enzyme activity of the soybean, cultivated the bacterium using powdered slate extract as a basic culture medium, and collected the spores in sterile sand. As a result of repeated pure cultivation in 1~1, a fixed strain with strong enzymatic activity was obtained, and surprisingly, when grains were fermented with this strain, it was found to be an excellent antitumor substance. The present invention has been completed based on the discovery that this can be produced.

従って、本発明L1新規な抗腫瘍性物質を提供するもの
でを)る。更に捷だ、本発明は、リゾプス・オリーセー
に属する新菌株を用いて新規万抗Pa瘍性物質を製造す
る方法を提供 3− するものである。
Therefore, the present invention provides a novel antitumor substance. More importantly, the present invention provides a method for producing a novel anti-Pan cancer substance using a new bacterial strain belonging to Rhizopus oryzae.

本発明で使用される、本発明者によって固定された菌株
は次のような自学的性状を有する。
The bacterial strain fixed by the present inventor and used in the present invention has the following autologous properties.

(1)形態的性質 コロニーは、ポテト・デキストロース寒天培地上、30
℃でけじめ白色のちに灰色をおひる。栄養菌糸はよく発
達し、生長が速く、巾23μmに至に、はふく枝を形成
する。#3ふく枝は基質に接着すると分枝した仮載を形
成する。胞子のり柄は菌糸から直接にも生えるが、典型
的な柄口會1ふく枝が基IJ!に接着して仮載を生じた
部位より生ずる。通常1本が直立し、時々2本直立する
。無分枝で、はじめ無色のちに褐色になる。中7.8〜
14μm 4− 胞子のうは球形〜血球形で、はじめ無色、成熟すると黒
色になる。胞子のり下部に直径62〜150 pmのア
ボフイシスをもつ。柱軸は亜球形〜卵形で、巾34〜1
10μmである。胞子を放出稜は杯をふせた形につぶれ
る。胞子はオリーブがかった灰色、6.6〜9、3 p
m X 4.6〜6.3μmで、表面にや一角ばった亜
球形〜卵形、ダ円形の縁状模様をもつ。
(1) Morphological characteristics Colonies were grown on potato dextrose agar medium at 30%
At ℃, it turns pale white and then turns gray. The vegetative hyphae are well developed, grow quickly, and form branches up to 23 μm in width. #3 When attached to the substrate, the #3 branches form a branched temporary support. Spore paste stalks can also grow directly from hyphae, but a typical stalk is called IJ! It is generated from the part where temporary mounting occurs due to adhesion to the surface. Usually one erect, sometimes two erect. Unbranched, initially colorless and then turning brown. Middle school 7.8~
14 μm 4- The sporangia are spherical to hematocyst-shaped, initially colorless, and turn black when mature. It has abophysis with a diameter of 62-150 pm at the bottom of the spore. The columnar axis is subspherical to oval, width 34-1
It is 10 μm. The ridge that releases the spores collapses into the shape of a closed cup. Spores olive-gray, 6.6-9, 3 p.
m x 4.6 to 6.3 μm, with a slightly angular subspherical to oval shape and a rounded edge pattern on the surface.

tW膜胞子は栄養菌糸、気中菌糸中に多数形成される早
生する、球形、卵形又は円筒形。接合胞子は観察されな
い。
tW membranous spores are formed in large numbers in vegetative hyphae and aerial hyphae, are early-growing, and are spherical, oval, or cylindrical in shape. No zygospores are observed.

(ID 生理的性質 q)生育範囲 温度=5℃で生育せず。10℃で貧弱。(ID Physiological properties q) Growth range No growth at temperature = 5°C. Poor at 10℃.

15〜40℃で生育。至適温度30℃0fl)I : 
s〜7 (2) NaCA耐塩性 1%生育良好。3%貧弱。5%生育せず。
Grows at 15-40℃. Optimum temperature 30℃0 fl)I:
s~7 (2) NaCA salt tolerance 1%, good growth. 3% poor. 5% did not grow.

■ v−pテストニー ■ 糖類の発酵性 D−グルコース(−Fl、D−フラクトース仕)、D−
iラフ)−ス(→、シュクロース(4)、マルトース(
→、スターチ(−F)、ラフィノースH1イヌリン(→
、グリセリン(ト) ■ クエン酸ナトリウムの利用二十 ■ コハク識ナトリウムの利用:+ ■ 窒素源の利用 硫酸アンモニウム(→、グルタミン酸ナトリウム(用、
ペプトン(→、硝酸ナトリウム(ハ)、亜硝酸ナトリウ
ム←) (!3)酸の生成(り゛ルコース)二十以上の1学的性
状について、■・■・1tlns(1950)及びZy
cha @t at (1969) ’に参照して検討
した結果、本菌株kまリゾプス・オリーゼ−に輌するが
、酵素活性が公知菌より俊っているので、新菌株と同定
し、リゾプス・オリーゼ・ウェット・エト・プリンセン
ーゲールリングス(Rhlzopum oryzae 
Went atPrlnaen −Ge@rl1gm 
) M −24(以下[リゾプス・オリーセーM−24
Jと称する)と命名し、工業技術院微生物工業技術研究
所に微工研菌寄第7195号(FbnMp−7195)
として寄託した。
■ v-p test knee ■ Fermentable sugars D-glucose (-Fl, D-fructose), D-
i rough)-su(→, sucrose (4), maltose (
→, starch (-F), raffinose H1 inulin (→
, Glycerin (T) ■ Use of sodium citrate 20 ■ Use of sodium citrate: + ■ Use of nitrogen sources Ammonium sulfate (→, Sodium glutamate (for),
Peptone (→, sodium nitrate (c), sodium nitrite ←) (!3) Acid production (relaxation) Regarding more than 20 monological properties, ■・■・1tlns (1950) and Zy
As a result of an investigation with reference to Cha@t at (1969), the present strain was found to be Rhizopus oryzae, but its enzymatic activity was higher than that of known bacteria, so it was identified as a new strain, and Rhizopus oryzae was identified as a new strain.・Rhlzopum oryzae
Went atPrlnaen -Ge@rl1gm
) M-24 (hereinafter referred to as [Rhizopus oryzae M-24
FbnMp-7195 and was designated as FbnMp-7195 by the Institute of Microbiology, Agency of Industrial Science and Technology.
Deposited as.

本発明の抗腫瘍性物質は、リゾプス・オリーゼ−M−2
4を用いて穀類を発酵させ、そ 7− の発酵液中の水溶性成分を採取することによって製造さ
れる。
The antitumor substance of the present invention is Rhizopus oryzae M-2.
It is produced by fermenting grains using 4 and collecting water-soluble components in the fermentation liquid.

本発明方法で発酵原料として使用される穀類としては、
例えば白米、〈す米、側木、麦、ひえ、あわ、きび、は
と麦、とうもろこし、こうりやん等が挙けられる。これ
らの穀類は水に浸漬して充分に吸水させた後、煮炊し、
これにリゾプス・オリーゼ−M−24を接種して発酵を
行う。発酵は最初が30℃で最後が40℃程度になるよ
うに日毎に昇温し、3〜5日間行うのが好ましい。
Grains used as fermentation raw materials in the method of the present invention include:
Examples include white rice, rice, side grain, barley, millet, millet, millet, barley, corn, and koriyan. These grains are soaked in water to absorb enough water, then boiled.
This is inoculated with Rhizopus oryzae-M-24 and fermentation is carried out. Fermentation is preferably carried out for 3 to 5 days by raising the temperature daily so that the temperature is 30°C at the beginning and about 40°C at the end.

斯くして得た発酵液に水を加え、濾過、遠心分離、傾斜
等によって不溶物を除去し、水溶液を採取する。この水
溶液を噴霧乾燥等により乾燥すれば抗腫瘍性物質が得ら
れる。
Water is added to the fermentation liquid thus obtained, and insoluble matter is removed by filtration, centrifugation, decanting, etc., and an aqueous solution is collected. An antitumor substance can be obtained by drying this aqueous solution by spray drying or the like.

 8− このようにして得らfl−る抗ll!J8瘍性物質は次
の如き物性含有する。
8- Thus obtained fl-ru anti-ll! J8 tumorous substance contains the following physical properties.

■ 元素分析値(約):C4o5’6、N7%、N1%
■ Elemental analysis value (approx.): C4o5'6, N7%, N1%
.

■ 分子蓋:5,000〜100,000゜■ 融 点
:明確な融点を示さないが、220℃以上で分解がみら
れる1、 C) 比旋光度:〔α)D59.9°(10%水)。
■Molecular cap: 5,000-100,000゜■Melting point: Does not show a clear melting point, but decomposition is observed above 220℃1.C) Specific optical rotation: [α)D59.9° (10% water).

■ 紫外t1iIm収スペクトル:257.263 n
m付近に極大吸収を有する(第1図)。
■ Ultraviolet t1iIm yield spectrum: 257.263 n
It has a maximum absorption near m (Fig. 1).

蟻)赤外線吸収スペクトル(KBr ) : 1650
.1400.1050crn−’ に土載ピークを有す
る(第2図)。
Ant) Infrared absorption spectrum (KBr): 1650
.. It has an overland peak at 1400.1050 crn-' (Fig. 2).

■ 溶剤に対する溶解性:水に易溶。メタノール、エタ
ノール、クロロホルム、エーテル、アセトン、酢酸エチ
ル及び゛n−ヘキサンに不溶。
■ Solubility in solvents: Easily soluble in water. Insoluble in methanol, ethanol, chloroform, ether, acetone, ethyl acetate and n-hexane.

■ 呈色反応:ピユーレット反応、キサントプロティン
反応、ミロン反応、アンスロン−伽。
■ Color reactions: Pieuret reaction, xanthoprotein reaction, Millon reaction, Anthrone-Kaya.

酸反応、フェノール硫酸反応及びシスティン倣酸反応は
陽性。
Acid reaction, phenol-sulfuric acid reaction, and cysteine mimic acid reaction were positive.

■ 塩基性、酸性、中性の区別二両性 (!9 物質の色:白色。■ Distinguish between basic, acidic, and neutral ampholytic (!9 Color of substance: white.

O糖含量エフエノール硫酸法により測定したグルコース
換算糖含有蓋は約85〜90%。
O-sugar content The sugar content in terms of glucose measured by the phenol sulfuric acid method is about 85-90%.

0 蛋白質含量:フオーリンーロウソー法で測定した牛
血清アルブミン換算蛋白質含有量は約1%。
0 Protein content: The protein content in terms of bovine serum albumin measured by the Folin-Rousseau method is approximately 1%.

斯くして得られた本発明の抗腫瘍性物質の当該効果を試
験した結果は次のとおりである。
The results of testing the effect of the antitumor substance of the present invention thus obtained are as follows.

試験例1 平均体ff12Ofの6週令BALB / e マウス
腹腔内にMsth−All!i!a細&を接種し、1週
間後に増殖1〜たlhl瘍細脳細胞水と共に抜き取り、
この細胞105個を他の6週令のBALB /CCママ
ウスそけい部皮下に移植し、実施例2で得た粉末標品を
注射用蒸留水に溶解し、移植稜3日目から1日1回1(
1%!/匹ずつ連続7日間l!1¥瘍内に直接投与した
。腫瘍移植5週間後の固型肺癌の直径または固型腫瘍を
摘出し、その重−mi試料の代りに生理食塩水を投与し
た対照区の場合と比較した。得られた結果を次の式によ
って表示した。
Test Example 1 Msth-All! was intraperitoneally administered to 6-week-old BALB/e mice with an average size of ff12Of. i! After one week, the LHL tumor cerebellum cells were extracted together with water.
105 of these cells were subcutaneously transplanted into the groin region of another 6-week-old BALB/CC mouse, and the powder preparation obtained in Example 2 was dissolved in distilled water for injection. Times 1 (
1%! /fish for 7 consecutive days! 1¥ Administered directly into the tumor. Five weeks after tumor implantation, the diameter of solid lung cancer or solid tumor was excised and compared with a control group in which physiological saline was administered instead of the heavy-mi sample. The obtained results were expressed using the following formula.

総マウス匹数 11− 第1表 試験例2 本発明の抗腫瘍性物質の投与によ抄完全治癒したマウス
は、これに新fcK腫瘍細胞を再接種してももはや生着
せす腫瘍の形成は見られない。
Total number of mice: 11 - Table 1 Test Example 2 Mice that were completely cured by administration of the antitumor substance of the present invention no longer formed engraftable tumors even if they were re-inoculated with new fcK tumor cells. can not see.

M@th−ムPIA瘍に対し本発明の物質を投与して完
全治癒したマウス(接種後6週)に対し、試験例1で述
べたと同様にして得られたM@th−Alli瘍細胞を
最初に腫瘍が形成され治癒したと反対側のそけい部皮下
に接種して12− その生殖腫瘍形成を調べた。これらの結果を第2表に示
す。
M@th-Alli tumor cells obtained in the same manner as described in Test Example 1 were administered to mice (6 weeks after inoculation) that had completely healed by administering the substance of the present invention to M@th-Alli tumor PIA tumors. First, the tumor was inoculated subcutaneously in the groin on the opposite side where the tumor had been formed and healed, and the reproductive tumor formation was examined. These results are shown in Table 2.

第2表 試験例3 平均体重22fの6週令のマウス(ICR系、雌)腹腔
内にサルコーマ180肺瘍細胞を接種し、1週間俵に増
植した腫瘍細胞を腹水と共に抜きと艶、この細胞4 X
 10’個を他の6週令マウス(ICR系雌)のそけい
皮下に移植し、実施例2で得た粉末標品を注射用蒸留水
に溶解し、移植後24時間目から1日1回1 f / 
’pずつ連続15日間経口投与した。腫瘍移植5週間後
の固型腫瘍の直径または固型腫瘍を摘出し、その重量を
試料の代抄に生理食塩水を投与した対照区の場合と比較
した。
Table 2 Test Example 3 Sarcoma 180 lung tumor cells were intraperitoneally inoculated into 6-week-old mice (ICR strain, female) with an average body weight of 22 f, and the tumor cells grown in bales for 1 week were removed together with ascites. Cell 4
10' mice were subcutaneously transplanted into the groin of another 6-week-old mouse (ICR female), and the powder preparation obtained in Example 2 was dissolved in distilled water for injection, and from 24 hours after transplantation, once a day. times 1 f/
'p was orally administered for 15 consecutive days. Five weeks after tumor implantation, the diameter of the solid tumor or the weight of the solid tumor was compared with that of a control group in which physiological saline was administered as a substitute for the sample.

中間経過については固型腫瘍の直径を測定することによ
って調べた。その結果は第3表の通りであり、粉末標品
を1回投与量tf、、’Kyで腫瘍発育は、経口投与で
も抑制された。
The interim course was investigated by measuring the diameter of solid tumors. The results are shown in Table 3, and tumor growth was inhibited by oral administration of the powder preparation at a single dose of tf, , 'Ky.

第3表 マウス及びラットを用いた急性毒性試験の結果、そのL
D、Q打j%給口投与でst7’icy以上、わ腔内投
力で29/に’−9以上であった。
Table 3 Results of acute toxicity tests using mice and rats, L
D and Q strokes were more than 7'icy when administered by mouth, and the intracavity injection force was more than 29/'-9.

以上の試験結果から明らかな如く、本発明の抗腫瘍性物
JJtは毒性が低く、各種腫瘍、特に治療困難とされて
いる固型til!瘍に対して優れた抑制作用含有する。
As is clear from the above test results, the antitumor substance JJt of the present invention has low toxicity and can be used to treat various tumors, especially solid til! Contains excellent suppressive action against tumors.

本発明の抗II!1!網性物質をヒト又は動物に投与す
るには、一般的方法を採用することができ、例えに経口
投与、皮下、筋肉内、静脈内もしくは[11! 動向注
射、直腸内投与、外用剤投与、点滴投与が可能である。
Anti-II of the present invention! 1! To administer the reticulum to humans or animals, conventional methods can be employed, such as oral administration, subcutaneous, intramuscular, intravenous or [11! It can be administered by injection, intrarectally, externally, or intravenously.

投与量は、腫瘍の種類、年令、症状等によって異なるが
、約0.2〜2,000Mg/Ky/IE、特に3〜5
o。
The dosage varies depending on the type of tumor, age, symptoms, etc., but is approximately 0.2 to 2,000 Mg/Ky/IE, especially 3 to 5
o.

 15− q/に9/日を1日1〜6回に分けて投与するのが好ま
しい。尚本発明の抗腫瘍性物質には免疫増強剤を併用す
ることもできる。
It is preferable to administer the drug in 1 to 6 divided doses per day, 15-q/day to 9/day. In addition, an immune enhancer can also be used in combination with the antitumor substance of the present invention.

次に実施例を挙けて説明する。Next, an example will be given and explained.

実施例1 (1)大豆60tを水に12時間浸漬して吸水させ、粉
砕抜水1tを加え、1時間煮沸する。
Example 1 (1) 60 tons of soybeans are soaked in water for 12 hours to absorb water, 1 ton of drained water is added, and the mixture is boiled for 1 hour.

これに塩化カルシウム7f′1を加えて凝固させ、不溶
性蛋白を除去し、F液に水1zを加えてム液とする。
Calcium chloride 7f'1 is added to this to coagulate it, insoluble protein is removed, and water 1z is added to solution F to make a mucus solution.

他方、馬鈴薯2009を0.196昇東水に1時間浸漬
した後、水洗し、剥皮し、これに水ltf加えて1時間
煮沸する。これを濾過し、p液に水を加えて1tとして
B液とする。
On the other hand, 2009 potatoes were soaked in 0.196 Shodong water for 1 hour, washed with water, peeled, and water LTF was added thereto and boiled for 1 hour. This is filtered, and water is added to the P solution to make 1 t, which is used as B solution.

上記ム及びB液を6対4の割合で混和して16− 基本培養液とする。Mix the above Mu and B solution in a ratio of 6:4 and make 16- Use as basic culture solution.

(11)粘板岩50fを粉砕(70〜80メツシユ以下
)シ、基本培養液500−に入れ、沸騰水浴上で30分
間加熱する。斯くして得た粘板岩抽出液を5〜10%に
なるように古本培養液に加え、培養液とする。
(11) Slate 50f is crushed (70 to 80 mesh or less), placed in basic culture solution 500, and heated on a boiling water bath for 30 minutes. The slate extract obtained in this manner is added to a used book culture solution at a concentration of 5 to 10% to obtain a culture solution.

(−) 有機物を殆んど含捷ない砂を蒸留水で充分に洗
浄し、160℃の乾熱殺菌器にて30分間焙焼する。
(-) Sand containing almost no organic matter is thoroughly washed with distilled water and roasted for 30 minutes in a dry heat sterilizer at 160°C.

(1v) 培養液をペトリシャーレに入れ、中国産1色
子より分離した糸状菌(リゾープス属)を接種し、25
〜30℃で5〜10日間培養し、充分に菌糸、胞子が増
殖した自体を選び、(iii)で得た砂50f中に入れ
、無菌箱中で充分に攪拌して混和する。これをシャーレ
に入れ、−4℃〜10℃の冷凍庫中に5目間保存した仮
、胞子を分離し、試験管培地(M@y@r氏の変成人工
培地)に1白金耳接種し、25〜30℃の恒温器中に5
〜10日保存した。この冷温、恒温保存を10回繰粉返
して行い、固定されたM−24株を得た。
(1v) Put the culture solution into a Petri dish, inoculate it with filamentous fungi (Rhizopus genus) isolated from Chinese Ishikiko, and inoculate it with 25
Cultivate at ~30°C for 5 to 10 days, select those that have sufficiently proliferated mycelia and spores, place them in 50f of sand obtained in step (iii), and stir thoroughly to mix in a sterile box. This was placed in a Petri dish and stored in a freezer at -4°C to 10°C for 5 days.The spores were separated and inoculated into a test tube medium (M@y@r's modified artificial medium) with one platinum loop. 5 in a thermostat at 25-30℃
Stored for ~10 days. This cold and constant temperature storage was repeated 10 times to obtain the fixed M-24 strain.

実施例2 精白米I Kyをよく洗浄した抜水に12時間浸漬して
充分に吸水させた後煮炊した。この白米に殺菌水400
−を加えてよく攪拌して混和し、これに実施例1で固定
し7’(M−24株を接種し、30℃で24時間、35
℃で24時間、更に40℃で24時間発酵を行った。こ
の発酵液に水1〜1.5t′(f−加え、45℃に加温
し、24時間後に濾過した。F”lの300℃、出口温
度80〜170℃)を用いて、滞留時間5〜80秒で乾
燥し、白色粉末の抗腫a性物質管得た。
Example 2 Polished rice I Ky was immersed in well-washed drained water for 12 hours to absorb sufficient water, and then boiled. 400 sterilized water for this white rice
- and stir well to mix, and inoculate this with the 7' (M-24 strain) fixed in Example 1.
Fermentation was carried out at 40°C for 24 hours and then at 40°C for 24 hours. 1 to 1.5 t' (f) of water was added to this fermentation liquid, heated to 45°C, and filtered after 24 hours. It dried in ~80 seconds to obtain a white powder anti-tumor substance tube.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発り]抗腫瘍性物質の紫外線吸収スペクトル
、第2図は同物質の赤外線吸収スペクトルである。 以上 出願人 篠 崎 晶 敬
Figure 1 shows the ultraviolet absorption spectrum of the antitumor substance, and Figure 2 shows the infrared absorption spectrum of the same substance. Applicant Akira Shinozaki

Claims (1)

【特許請求の範囲】 1、 次の物性を有する抗腫瘍性物質、■ 元素分析値
(約):C40%、H7%、NIX。 ■ 分子量:5,000〜100,000゜■ 融 点
:明確な融点を示さないが、220℃以上で分解がみら
れる。 ■ 比旋光度:〔α)D59.9°(10%水)。 ■ 紫外線吸収スペクトル: 257.26anm付近
に極大吸収を有する。 ■ 赤外線吸収スペクトル(KBr ) : 1650
 。 1400.1050 on−1に上狭ビークを有する。 ■ 溶剤に対する溶解性:水に易溶。メタノール、エタ
ノール、クロロホルム、エーテル、アセトン、酢酸エチ
ル及びn−ヘキサンに不溶。 申)呈色反応:ピユーレット反応、キサントプロティン
反応、ミロン反応、アンスロン−硫酸反応、フェノール
硫酸反応及びシスティン硫酸反応は陽性。 ■ 塩基性、酸性、中性の区別:両性 [相] 物質の色:白色。 0 糖含量:フェノール硫酸法により測定したダルコー
ス換算糖含有量は約85〜90%。 [相] 蛋白質含ft:フオーリンーロウリー法で測定
した牛血清アルブミン換算蛋白質含有量は約1%。 2、 リゾプス・オリーゼ−M−24株を用いて穀類を
発酵させ、その発#捨中の水溶性成分を採取することを
%徴とする抗腫瘍性物質の製造法。
[Claims] 1. An antitumor substance having the following physical properties: (1) Elemental analysis values (approximately): C40%, H7%, NIX. ■Molecular weight: 5,000-100,000゜■Melting point: Does not show a clear melting point, but decomposition is observed above 220°C. ■ Specific optical rotation: [α) D59.9° (10% water). ■ Ultraviolet absorption spectrum: Maximum absorption near 257.26 nm. ■ Infrared absorption spectrum (KBr): 1650
. 1400. Has an upper narrow peak at 1050 on-1. ■ Solubility in solvents: Easily soluble in water. Insoluble in methanol, ethanol, chloroform, ether, acetone, ethyl acetate and n-hexane. Mon) Color reaction: Piuret reaction, xanthoprotein reaction, Myron reaction, Anthrone-sulfuric acid reaction, phenol-sulfuric acid reaction, and cysteine-sulfuric acid reaction are positive. ■ Distinction between basic, acidic, and neutral: amphoteric [phase] Color of substance: white. 0 Sugar content: The sugar content in terms of dulcose measured by the phenol-sulfuric acid method is about 85-90%. [Phase] Protein content: The protein content measured by the Farin-Lowry method is approximately 1% in terms of bovine serum albumin. 2. A method for producing an antitumor substance, which comprises fermenting grains using Rhizopus oryzae M-24 strain and collecting water-soluble components from the fermentation.
JP58151417A 1983-08-19 1983-08-19 Antitumor agent and its preparation Granted JPS6043387A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58151417A JPS6043387A (en) 1983-08-19 1983-08-19 Antitumor agent and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58151417A JPS6043387A (en) 1983-08-19 1983-08-19 Antitumor agent and its preparation

Publications (2)

Publication Number Publication Date
JPS6043387A true JPS6043387A (en) 1985-03-07
JPS6141551B2 JPS6141551B2 (en) 1986-09-16

Family

ID=15518153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58151417A Granted JPS6043387A (en) 1983-08-19 1983-08-19 Antitumor agent and its preparation

Country Status (1)

Country Link
JP (1) JPS6043387A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104360012A (en) * 2014-12-04 2015-02-18 福建农林大学 Kit for simultaneously and rapidly measuring content of glucose, fructose and total sugar and application of kit
CN106860781A (en) * 2017-02-27 2017-06-20 中国农业大学 A kind of application of Rhizopus oryzae solid state fermentation extract, preparation method and its anticancer function

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104360012A (en) * 2014-12-04 2015-02-18 福建农林大学 Kit for simultaneously and rapidly measuring content of glucose, fructose and total sugar and application of kit
CN106860781A (en) * 2017-02-27 2017-06-20 中国农业大学 A kind of application of Rhizopus oryzae solid state fermentation extract, preparation method and its anticancer function

Also Published As

Publication number Publication date
JPS6141551B2 (en) 1986-09-16

Similar Documents

Publication Publication Date Title
CN108901615A (en) Utilize the method for trollflower pharmacological property culture medium culture cordyceps mycelium
JP2001231545A (en) Separated strain of antrodia camphorata, method for producing the culture product, and product obtained therefrom
CN111088300A (en) Fermentation preparation method of eurotium cristatum melanin
JPH01228480A (en) Production of extract of cultured mycelia of edible basidiomycete
CH641204A5 (en) ANTITUMOR SUBSTANCE OBTAINED BY CULTURE OF MYCELIUM.
TWI279439B (en) Processes for producing an antrodia camphorata culture having pharmacological activity, processes for obtaining a pharmacologically active composition from a culture of a. camphorata, products produced thereby and pharmaceutical compositions for the...
TWI729928B (en) Concentrate of phellinus linteus extract, method of manufacturing the same and use of the same for preparing composition of improving sleep
WO1998056755A1 (en) Physiologically active substances tkr2449, process for producing the same, and microorganism
CN114107414B (en) Method for preparing balsam pear polypeptide by fermentation method
JPS6043387A (en) Antitumor agent and its preparation
CN115634241A (en) Preparation method of Shandong ganoderma lucidum extract and application of Shandong ganoderma lucidum extract in preparation of hypoglycemic drugs
KR100398677B1 (en) Cultivation Method of mushroom mycelium using citrus juice and mushroom mycelium thereof
CN115011485A (en) Phellinus linteus mycelium and/or its derivative, its preparation method and its use for preparing sleep improving composition
JPS60186260A (en) Powdery mushroom extract composition
TW202216182A (en) Use of phellinus linteus for preparing composition of improving sarcopenia
JPH11302191A (en) Immunoactivator and antitumor agent containing extract from lyophyllum decastes (fr.) sing. as active ingredient
JPH11209301A (en) Protein polysaccharide 0041
US3276972A (en) Process for the preparation of ergotamine and ergotaminine in submerged culture and under aerobic conditions
JPH0655133B2 (en) Method for culturing mycelium having anti-cancer effect
JP3152402B2 (en) Antitumor agent and method for producing the same
JPS62130B2 (en)
JPH01121302A (en) Mucilaginous polysaccharide substance and production thereof
SU676610A1 (en) Method of producing infectious medium thielariopsis basicola
CN115627284A (en) Method for high yield of extracellular polysaccharide by black skin termitomyces albuminosus
FR2463185A1 (en) POLYSACCHARIDES COMPRISING ANTI-CANCER ACTIVITY FROM THE CULTURE OF A STRAIN OF THE GENUS ISARIA AND THEIR PRODUCTION PROCESS